CTOs on the Move

Johnson Mathers Health Care Inc

www.johnsonmathers.org

 
Johnson Mathers Health Care Inc is a Carlisle, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Hilco/Wilson Smart Optical Solutions

Hilco/Wilson Smart Optical Solutions is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Plainville, MA. To find more information about Hilco/Wilson Smart Optical Solutions, please visit www.hilco-usa.com

Osler Health

Osler Health is on the vanguard of medical providers making the transition from being service providers to clinical managers. That means we are also responsible for the totality of each patients care. Osler Health is committed to providing the right care, at the right time, and, at the right cost to deliver the best results. That is why we do not partner with hospitals so that we are rewarded for your good health, not when you lose it. Osler is ranked in the top 10% nationally for quality, and 100% of our practices use advanced technology. Osler patients are also 112% healthier relative to peer groups. Our Mission – To improve the health status of each patient efficiently, effectively and with the highest quality care. Our Vision – To transform healthcare from a Managing Sickness model to a Preserving Wellness model.

Accord BioPharma

Foresee is a Taiwan and US-based biopharmaceutical company listed on the Taipei Exchange (6576.TWO). Foresee`s R&D efforts are focused in two key areas, namely its unique stabilized injectable formulation (SIF) depot delivery technology with derived drug products targeting specialty markets, and secondly its transformative preclinical and clinical first-in-class NCE programs targeting rare and severe disease areas with high unmet needs. Foresee`s product portfolio includes late stage and early stage programs. CAMCEVI® 42 mg is now approved in the U.S. and under regulatory review in the EU. Additionally, U.S. and EU regulatory submissions are in preparation for CAMCEVI® 21 mg. FP-025 – a highly selective oral MMP-12 inhibitor targeting inflammatory and fibrotic diseases, currently in Phase 2/3 studies, including a Phase 2/3 study for COVID-19 virus-induced acute respiratory distress syndrome (ARDS). FP-045 – a highly selective oral small molecule allosteric activator of ALDH2, a mitochondrial enzyme, for which a Phase 1b/2 study is currently planned for Fanconi Anemia.

Omnica Corporation

Omnica Corporation is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ForeSee Health

ForeSee Health is a Chesterfield, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.